vs
Alpha Metallurgical Resources, Inc.（AMR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Alpha Metallurgical Resources, Inc.的1.2倍（$622.0M vs $519.1M），Royalty Pharma plc净利率更高（34.4% vs -3.3%，领先37.8%），Royalty Pharma plc同比增速更快（4.8% vs -15.7%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -22.4%）
阿尔法冶金资源（前身为康图拉能源）是行业领先的煤炭供应商，在阿巴拉契亚北部和中部拥有地下及露天煤矿综合体，在宾夕法尼亚州、弗吉尼亚州和西弗吉尼亚州坐拥大型煤田，生产用于炼钢的冶金煤和用于发电的动力煤，供应全球下游客户。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AMR vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$519.1M
营收增速更快
RPRX
高出20.4%
-15.7%
净利率更高
RPRX
高出37.8%
-3.3%
两年增速更快
RPRX
近两年复合增速
-22.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $519.1M | $622.0M |
| 净利润 | $-17.3M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -4.1% | 62.4% |
| 净利率 | -3.3% | 34.4% |
| 营收同比 | -15.7% | 4.8% |
| 净利润同比 | -711.2% | 2.9% |
| 每股收益（稀释后） | $-1.35 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRRPRX
| Q4 25 | $519.1M | $622.0M | ||
| Q3 25 | $525.2M | $609.3M | ||
| Q2 25 | $548.7M | $578.7M | ||
| Q1 25 | $529.7M | $568.2M | ||
| Q4 24 | $615.4M | $593.6M | ||
| Q3 24 | $669.8M | $564.7M | ||
| Q2 24 | $800.1M | $537.3M | ||
| Q1 24 | $861.3M | $568.0M |
净利润AMRRPRX
| Q4 25 | $-17.3M | $214.2M | ||
| Q3 25 | $-5.5M | $288.2M | ||
| Q2 25 | $-5.0M | $30.2M | ||
| Q1 25 | $-33.9M | $238.3M | ||
| Q4 24 | $-2.1M | $208.2M | ||
| Q3 24 | $3.8M | $544.0M | ||
| Q2 24 | $58.9M | $102.0M | ||
| Q1 24 | $127.0M | $4.8M |
营业利润率AMRRPRX
| Q4 25 | -4.1% | 62.4% | ||
| Q3 25 | -0.5% | 70.1% | ||
| Q2 25 | 0.5% | 36.3% | ||
| Q1 25 | -7.6% | 94.0% | ||
| Q4 24 | 1.6% | 60.9% | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 8.8% | 50.2% | ||
| Q1 24 | 16.5% | -13.0% |
净利率AMRRPRX
| Q4 25 | -3.3% | 34.4% | ||
| Q3 25 | -1.1% | 47.3% | ||
| Q2 25 | -0.9% | 5.2% | ||
| Q1 25 | -6.4% | 41.9% | ||
| Q4 24 | -0.3% | 35.1% | ||
| Q3 24 | 0.6% | 96.3% | ||
| Q2 24 | 7.4% | 19.0% | ||
| Q1 24 | 14.7% | 0.8% |
每股收益（稀释后）AMRRPRX
| Q4 25 | $-1.35 | $0.49 | ||
| Q3 25 | $-0.42 | $0.67 | ||
| Q2 25 | $-0.38 | $0.07 | ||
| Q1 25 | $-2.60 | $0.55 | ||
| Q4 24 | $-0.09 | $0.46 | ||
| Q3 24 | $0.29 | $1.21 | ||
| Q2 24 | $4.49 | $0.23 | ||
| Q1 24 | $9.59 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $415.6M | $618.7M |
| 总债务越低越好 | $9.8M | $9.0B |
| 股东权益账面价值 | $1.5B | $9.7B |
| 总资产 | $2.3B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AMRRPRX
| Q4 25 | $415.6M | $618.7M | ||
| Q3 25 | $457.9M | $938.9M | ||
| Q2 25 | $449.0M | $631.9M | ||
| Q1 25 | $448.0M | $1.1B | ||
| Q4 24 | $481.6M | $929.0M | ||
| Q3 24 | $484.6M | $950.1M | ||
| Q2 24 | $336.1M | $1.8B | ||
| Q1 24 | $269.4M | $843.0M |
总债务AMRRPRX
| Q4 25 | $9.8M | $9.0B | ||
| Q3 25 | $2.9M | $8.9B | ||
| Q2 25 | $3.1M | $8.0B | ||
| Q1 25 | $2.4M | $7.6B | ||
| Q4 24 | $2.9M | $7.6B | ||
| Q3 24 | $3.6M | $7.6B | ||
| Q2 24 | $5.3M | $7.6B | ||
| Q1 24 | $6.0M | $6.1B |
股东权益AMRRPRX
| Q4 25 | $1.5B | $9.7B | ||
| Q3 25 | $1.6B | $9.6B | ||
| Q2 25 | $1.6B | $9.5B | ||
| Q1 25 | $1.6B | $9.8B | ||
| Q4 24 | $1.6B | $10.3B | ||
| Q3 24 | $1.7B | $10.3B | ||
| Q2 24 | $1.6B | $9.8B | ||
| Q1 24 | $1.6B | $9.9B |
总资产AMRRPRX
| Q4 25 | $2.3B | $19.6B | ||
| Q3 25 | $2.3B | $19.3B | ||
| Q2 25 | $2.4B | $18.3B | ||
| Q1 25 | $2.4B | $17.6B | ||
| Q4 24 | $2.4B | $18.2B | ||
| Q3 24 | $2.5B | $18.0B | ||
| Q2 24 | $2.5B | $17.7B | ||
| Q1 24 | $2.5B | $16.1B |
负债/权益比AMRRPRX
| Q4 25 | 0.01× | 0.92× | ||
| Q3 25 | 0.00× | 0.93× | ||
| Q2 25 | 0.00× | 0.84× | ||
| Q1 25 | 0.00× | 0.78× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | 0.00× | 0.74× | ||
| Q2 24 | 0.00× | 0.78× | ||
| Q1 24 | 0.00× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | — |
| 自由现金流率自由现金流/营收 | -1.9% | — |
| 资本支出强度资本支出/营收 | 5.6% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $17.8M | — |
8季度趋势，按日历期对齐
经营现金流AMRRPRX
| Q4 25 | $19.0M | $827.1M | ||
| Q3 25 | $50.5M | $702.6M | ||
| Q2 25 | $53.2M | $364.0M | ||
| Q1 25 | $22.2M | $596.1M | ||
| Q4 24 | $56.3M | $742.5M | ||
| Q3 24 | $189.5M | $703.6M | ||
| Q2 24 | $138.1M | $658.2M | ||
| Q1 24 | $196.1M | $664.6M |
自由现金流AMRRPRX
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $25.4M | — | ||
| Q2 25 | $18.6M | — | ||
| Q1 25 | $-16.3M | — | ||
| Q4 24 | $13.6M | — | ||
| Q3 24 | $158.0M | — | ||
| Q2 24 | $77.0M | — | ||
| Q1 24 | $132.5M | — |
自由现金流率AMRRPRX
| Q4 25 | -1.9% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | -3.1% | — | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 23.6% | — | ||
| Q2 24 | 9.6% | — | ||
| Q1 24 | 15.4% | — |
资本支出强度AMRRPRX
| Q4 25 | 5.6% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 7.3% | — | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | 7.4% | — |
现金转化率AMRRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 49.81× | 1.29× | ||
| Q2 24 | 2.34× | 6.45× | ||
| Q1 24 | 1.54× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMR
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
